Previous studies confirmed that p53 mutation occurs in 96% of high-grade serous ovarian cancers and mutations in p53 and Kras promote ovarian cancer by transforming primary tubal epithelial cells into cancer cells in mice (Tarangelo et al., 2018). Here, TP53 is linked to ovarian cancer.